Top Markets
#1 PulseChain PulseChain +45.01%
#2 RedStone RedStone +18.83%
#3 Bitway Bitway +12.19%
#4 Glidr Glidr +9.69%
#5 SkyAI SkyAI +8.74%
#6 OPENLOOT OPENLOOT +8.58%
#7 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.71%
#8 Pump.fun Pump.fun +7.24%
#9 Unit Pump Unit Pump +7.24%
#10 Tornado Cash Tornado Cash +7.07%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Lukas Biomedical Inc. Lukas Biomedical Inc.

Lukas Biomedical Inc.

6814
Rank in Stocks #27949
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc.... Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
Share Price
$0.70911832
Market Cap
$29.69M
Change (1 day)
0.45%
Change (1 year)
-9.36%
Country
TW
Trade Lukas Biomedical Inc. (6814)

Category

Healthcare
Number of shares outstanding for Lukas Biomedical Inc. (6814)
Number of shares outstanding as of August 2026: 0
According to Lukas Biomedical Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Lukas Biomedical Inc. (6814) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH